Cerebrovascular Disease and Interventional Neurology*

*You must be registered for the ANA2021 Virtual Annual Meeting to access the live SIG Series sessions.

Date/Time ET: Monday, December 13, 2021 - 11:30 AM  – 1:00 PM

Description: Although stroke remains the fifth leading cause of death and the number one cause of serious long-term disability in the US, effective acute treatments (thrombolysis and thrombectomy) that reduce death and disability are available and indications keep expanding and evolving. Through case-based presentations and overview of current evidence, faculty will provide emerging applications of interventional treatments. This session with cover important topics, in particular: 1) preclinical and translational thrombolytic therapies; 2) advances in neuroimaging to define the ischemic core and penumbra; and 3) the continuously evolving role of flow diverting stents.

Chair: Diogo C. Haussen, MD, Emory University

Co-Chair: Alexandra Czap, MD, McGovern Medical School, University of Texas Health Science Center at Houston


  • Understand the future of thrombolytic therapies and the barriers to stroke treatment
  • Review advances in neuroimaging to improve accuracy of patient triage and treatment
  • Learn why large necked aneurysms were difficult to treat and how flow diverting stents revolutionized this landscape


Novel Preclinical Therapies for Thrombolysis


Shahid Nimjee, MD, PhD

The Ohio State University, Medical Center

Determination of the Ischemic Core


Seena Dehkharghani, MD

New York University, Langone Health

Flow Diverting Stents: Aneurysms and Beyond


Maxim Mokin, MD, PhD

University of South Florida

Safety and Efficacy of Endovascular Therapy Referred by Telephone-based vs In-person Consultations

Oral Presenter: 

Sarah Nelson, MD, PhD

Mount Sinai Health System

*This session is not available for AMA PRA Category I Credit(s)™